Abstract
Introduction: Different tobacco products release different compounds; each compound, and each mixture, has different toxicological characteristics. There is a need to systematically record the emissions of the different tobacco products.
Methods: The papers reporting the emissions from conventional, electronic and heated (HTP) cigarettes published after 2010. The Scopus and Pubmed databases are used using appropriate key words; also the PMI file submitted to FDA for the iQOS notification is used.
Results: Table1 shows the basic bibliometric results of this research.
Cigarettes | ecigs | HTP | ||
Articles used | 440 | 222 | 85 | |
Journals | 153 | 85 | 39 | |
Papers affiliated to tobacco industry | 171 | 32 | 48 | |
Papers reporting | gas emissions | 272 | 165 | 71 |
metals | 75 | 31 | 18 | |
particles (physical or chemical characteristics) | 220 | 76 | 51 | |
tar | 59 | - | 9 |
Table2 shows the number of compounds reported in gas and particulate phase for each type of product.
Cigarettes | ecigs | HTP | PMI | |
Compounds in gas phase | 7025 | 1656 | 1982 | 505 |
Unique compounds in gas phase | 1609 | 558 | 494 | 277 |
Metals | 1216 | 338 | 156 | 66 |
Unique metals | 70 | 60 | 34 | 24 |
Compounds in particles | 2319 | - | 551 | 339 |
Unique compounds in particles | 397 | - | 516 | 339 |
Unique compounds in both gas and particles | 1808 | - | 937 | 605 |
Different physical characteristics of particles | 661 | 143 | 107 | 10 |
Unique physical characteristics of particles | 69 | 36 | 26 | 3 |
The gas compounds both in cigs/ecigs are 232, in cigs/HTP 287, in ecigs/HTP 152 and in HTP/PMI 233. The metals both in cigs/ecigs are 57, in HTP/PMI 22, while all found in HTP (34) are dound in cigs and ecigs. The PM compounds in both cigs/HTP are 47 and in HTP/PMI 336.
Conclusions: Cigarettes emit a high number of compounds, while these numbers are quite similar in the case of ecigs and HTPs.
Footnotes
Cite this article as: European Respiratory Journal 2021; 58: Suppl. 65, PA3203.
This abstract was presented at the 2021 ERS International Congress, in session “Prediction of exacerbations in patients with COPD”.
This is an ERS International Congress abstract. No full-text version is available. Further material to accompany this abstract may be available at www.ers-education.org (ERS member access only).
- Copyright ©the authors 2021